Pharma platform company China Medical System Holdings has tapped up existing partner Insilico for a 1.2 billion yuan ($177 million)...
One of the year’s largest venture funding rounds comes just after a head-to-head study showed Ollin’s drug — licensed from a China-based...
Eli Lilly has expanded its relationship with Abbisko Therapeutics, committing up to $1.9 billion to get the Chinese biotech to apply its...
A new gene-editing startup negotiated contracts with a Chinese company, raised $230 million in funding, and executed a reverse-merger...
Medicare Advantage plans that receive four out of five stars or better get bonus payments, which have ballooned to $16 billion this year.
The first-in-class EGFRxHER3 bispecific ADC that BMS paid $800 million for has shown strong phase 3 results from China that suggest it...
The United States will allocate five billion dollars for scientific research. This funding will address chronic diseases and accelerate...
QDENGA, India’s first dengue vaccine, receives approval for use, marking a significant milestone in dengue prevention efforts.
Biotech startup Zumutor Biologics has raised $7.3 Mn (about ₹70 Cr) in its Series B funding round from existing investors…
AI-focused VC firm raises $800M, Merck's new cholesterol pill, and more biotech news from The Readout
A rare disease startup with a mission to repurpose proven drugs has licensed a Chinese formulation of a well-known medicine and set its...
J&J’s shares ticked down as oncology sales missed expectations. Elsewhere, AstraZeneca bet $600 million on a lung cancer drug and a pair...
AstraZeneca is paying Sino Biopharmaceutical $200 million upfront for ex-China rights to a late-phase challenger to Merck & Co.’s...
AstraZeneca has added another piece to its sprawling interface with CSPC Pharmaceutical, paying the Chinese biotech $30 million upfront...
A Fosun Pharma subsidiary has paid Junshi Biosciences 215 million yuan ($32 million) for Chinese rights to a near-approval autoimmune...
Insilico Medicine has signed a deal worth up to $600 million with Japanese Big Pharma Takeda to collaborate on discovery of assets...
U.S.-based Boulevard Bio is paying $20 million upfront to China’s Metis TechBio for the global rights to a trispecific T-cell engager...
CAR-T cell therapy has flourished since it was first used in 2010, leading to eight approved medicines for different blood cancers. But...
The focus of the company is SERP-01, an in vivo base editing program targeting AATD developed in China and licensed from YolTech Therapeutics.
While dealmaking and investment dollars may be flowing across biopharma once again, acute challenges tied to policy, pricing and more...
In another biotech born out of China’s “NewCo” model, cAMPfield Therapeutics has launched with a $180 million series A and a focus on...
A federal jury in Delaware has found that Amgen and its acquired Teneobio willfully infringed on an antibody patent held by Harbour...
In 2017, a little-known company called Nanjing Legend Biotech walked into the ASCO annual meeting at the 11th hour, dropped a 100%...
Days after its lead clinical-stage asset suffered a setback, Agios Pharmaceuticals has rebounded by buying a blood disorder drug that...
Within hours of securing a gastrointestinal drug from Korea’s Hanmi Pharma, Eli Lilly has ramped up the biobucks for a wider-ranging...
For biopharmaceutical companies, Japan is one of the world’s most important markets, but also among the most operationally complex. Many...
For years, cell therapy has carried one of oncology’s most striking contradictions. It has changed the outlook for some blood cancer...
ChemT Biotechnology, a US‑Singapore startup that claims it has built an “intelligence layer” for bio-manufacturing, has raised a total...
Qdenga could be responsible for enhancing dengue in children who have not had an infection yet in their lives. In such cases, the...
arXiv:2607.21561v1 Announce Type: cross Abstract: Molecular property prediction from structure often uses a single representative...
Biotech startup Farm Watt has netted ₹32.5 Cr ($3.3 Mn) in a funding round co-led by India Angel Networks’ VC…
Takeda’s two-dose QDENGA vaccine, approved by the Drug Controller General of India, can be administered without prior dengue screening...
arXiv:2607.16087v1 Announce Type: cross Abstract: AlphaFold2's 93 million parameters, shaped by the evolutionary record of protein...
The early-stage trial will enroll 50 healthy adults to assess the vaccine's safety and immune response.
arXiv:2607.07866v1 Announce Type: new Abstract: Designing protein sequences that bind specific ligands benefits from an inverse-folding...
arXiv:2606.23745v1 Announce Type: new Abstract: We present JEDEL, a framework for generating synthesis-ready DNA-encoded libraries...
arXiv:2606.22138v1 Announce Type: cross Abstract: We present BioMatrix, the first multimodal foundation model that natively integrates...
In this week’s edition of The Hindu Health Wrap, we discuss a promising study that could help predict lung cancer years before...